THE ANALYSIS OF NEW DRUG REIMBURSEMENT DECISION MAKING IN SOUTH KOREA AFTER THE INTRODUCTION OF POSITIVE LISTING SYSTEM

被引：1
|
作者：
Kim, S. [1 ]
Cho, H. [1 ]
Yoo, H. [2 ]
Cho, J. [3 ]
Kang, K. [4 ]
Kim, J. [5 ]
机构：
[1] Novartis Korea, Seoul, South Korea
[2] AstraZeneca Korea, Seoul, South Korea
[3] Lilly Korea, Seoul, South Korea
[4] Abbvie Korea, Seoul, South Korea
[5] Ipsen Korea, Seoul, South Korea
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.1670
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP138
引用
收藏
页码：A676 / A676
页数：1
相关论文
共 50 条
  • [1] THE ANALYSIS OF THE DRUG REIMBURSEMENT DECISIONS BEFORE AND AFTER THE POSITIVE LIST SYSTEM IN SOUTH KOREA
    Hong, J. M.
    Jang, S.
    Yang, B. M.
    Lee, H. J.
    Kwon, H. Y.
    Park, M. H.
    Bae, E. Y.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A12 - A12
  • [2] Manufacturers' perceptions of the decision-making process for new drug reimbursement in South Korea
    Son, Kyung-Bok
    Park, Sylvia
    You, Myoungsoon
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2021, 37 (01)
  • [3] Drug Reimbursement Decision-Making in Thailand, China, and South Korea
    Ngorsuraches, Surachat
    Meng, Wei
    Kim, Bo-Yeon
    Kulsomboon, Vithaya
    [J]. VALUE IN HEALTH, 2012, 15 (01) : S120 - S125
  • [4] ANALYSIS OF IMPACTS OF THE SUPPLEMENTARY SCHEMES ON THE DRUG REIMBURSEMENT DECESION-MAKING UNDER THE POSITIVE LIST SYSTEM IN KOREA
    Kim, T.
    [J]. VALUE IN HEALTH, 2018, 21 : S63 - S63
  • [5] MEASURING THE IMPORTANCE OF DECISION MAKING CRITERIA FOR ANTICANCER DRUG REIMBURSEMENT IN KOREA
    Kwon, S.
    Park, S.
    Lee, E.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A477 - A477
  • [6] An Industry Survey on Unmet Needs in South Korea's New Drug Listing System
    Kim, Sungju
    Lee, Ji Yeon
    Cho, Seong Ha
    Shin, Eileen J.
    Kim, Minyoung
    Lee, Jong Hyuk
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (04) : 759 - 768
  • [7] An Industry Survey on Unmet Needs in South Korea’s New Drug Listing System
    Sungju Kim
    Ji Yeon Lee
    Seong Ha Cho
    Eileen J. Shin
    Minyoung Kim
    Jong Hyuk Lee
    [J]. Therapeutic Innovation & Regulatory Science, 2023, 57 : 759 - 768
  • [8] ANOTHER HURDLE IN ANTICANCER NEW DRUG LISTING IN KOREA-SETTING THE REIMBURSEMENT SCOPE
    Kim, S.
    Shin, E.
    Koo, J.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S351 - S351
  • [9] THE PRICE NEGOTIATION ON PHARMACEUTICALS AFTER THE INTRODUCTION OF POSITIVE LIST SYSTEM IN SOUTH KOREA
    Yoon, S. Y.
    Lee, E. K.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A143 - A143
  • [10] Price-Cutting Trends in New Drugs after Listing in South Korea: The Effect of the Reimbursement Review Pathway on Price Reduction
    Kim, Sungju
    Lee, Jong Hyuk
    [J]. HEALTHCARE, 2020, 8 (03)
12345